13th March 2018
We are happy to announce that SofMat’s Chief Executive Officer, Dr Philip Harrison, will be speaking at the 2018 Pharma Anti-Counterfeiting and Brand Protection Summit in Philadelphia on Tuesday 27th March.
More than 1 million people a year are dying from counterfeit drugs. In addition to this overwhelming social impact, the economic effects threaten a profitable industry meant to provide life-saving drugs all over the world. Product recall costs, lost sales and industry fines constantly plague industry operations. With the recent Drug Diversion and Counterfeit Crackdown Act of 2017 and Operation Pangea X, awareness is at its peak and will continue to grow. It is time to join the conversation and push the issues forward for in the hopes of finding solutions.
The conference is a dedicated Pharma industry event, held this year at the Hilton Garden Inn Philadelphia City Centre. This is an exciting opportunity for SofMat to join the international discussion on how to protect the public from counterfeit products and we look forward to discussing with conference attendees how SofMat’s technology platform can help them to combat this global problem.
Dr Harrison can be contacted on 0044 (0)7944 607094 or via email at email@example.com for anyone wishing to make an appointment for a face-to-face discussion in Philadelphia.